Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SUSAN M JACKSON

Allopathic & Osteopathic Physicians Family Medicine

NPI
1780749671
CMS profile
353603
Location
HALLSTEAD, PA

General Payments · PY2018–2024

$5,985.92

  • Reported across 352 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$843.69

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $843.69 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $505.09 7
Novo Nordisk AS $221.96 6
Janssen Pharmaceuticals, Inc $116.64 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,358.47 198
PY2019 $1,262.16 96
PY2020 $362.03 10
PY2021 $450.56 14
PY2022 $341.63 8
PY2023 $367.38 12
PY2024 $843.69 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $105.79 02/13/2024 Food and Beverage Undisputed 01/23/2026 1104462648 CMS
AstraZeneca Pharmaceuticals LP $19.56 03/22/2024 Food and Beverage Undisputed 01/23/2026 1105745524 CMS
AstraZeneca Pharmaceuticals LP $89.06 04/11/2024 Food and Beverage Undisputed 01/23/2026 1105321713 CMS
AstraZeneca Pharmaceuticals LP $116.64 04/17/2024 Food and Beverage Undisputed 01/23/2026 1105513757 CMS
AstraZeneca Pharmaceuticals LP $114.58 06/06/2024 Food and Beverage Undisputed 01/23/2026 1104468090 CMS
AstraZeneca Pharmaceuticals LP $15.98 09/13/2024 Food and Beverage Undisputed 01/23/2026 1105432398 CMS
AstraZeneca Pharmaceuticals LP $43.48 09/17/2024 Food and Beverage Undisputed 01/23/2026 1104707681 CMS
Janssen Pharmaceuticals, Inc $116.64 11/06/2024 Food and Beverage Undisputed 01/23/2026 1078149913 CMS
Novo Nordisk Inc $24.10 08/31/2024 Food and Beverage Undisputed 01/23/2026 1097313573 CMS
Novo Nordisk Inc $26.32 10/04/2024 Food and Beverage Undisputed 01/23/2026 1097050081 CMS
Novo Nordisk Inc $117.19 10/23/2024 Food and Beverage Undisputed 01/23/2026 1096620816 CMS
Novo Nordisk Inc $17.16 10/25/2024 Food and Beverage Undisputed 01/23/2026 1096845288 CMS
Novo Nordisk Inc $13.56 10/25/2024 Food and Beverage Undisputed 01/23/2026 1096965909 CMS
Novo Nordisk Inc $23.63 11/16/2024 Food and Beverage Undisputed 01/23/2026 1096823247 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.